معرفی
Sunil Thomas, PhD, is a Research Professor at the Lankenau Institute for Medical Research (LIMR), with a distinguished career in translational science. His work bridges microbiology, immunology, molecular biology, and cell biology to develop diagnostic tools and vaccines for diseases affecting millions globally. He has held academic titles at LIMR since 2012, including Research Assistant Professor, Research Associate Professor, and now Research Professor.
- Current roles: Research Professor (2022–Present), Editor of Vaccine Design: Methods and Protocols (Springer-Nature), and Visiting Professor at Temple University (2017).
- Education: BSc in Botany (Kerala University), MSc in Biotechnology (Cochin University of Science and Technology), PhD in Environmental Biotechnology (Cochin University), and Postdoctoral Fellowship at Mount Sinai School of Medicine.
Research interests encompass translational studies on immunotherapies for ulcerative colitis and Alzheimer’s disease, focusing on Bin1 monoclonal antibodies. He has pioneered structure-based vaccines for ehrlichiosis, modeled SARS-CoV-2 membrane proteins, and developed diagnostic tools like the ELISA kit for T-cell lipid rafts and Eastern Blotting for post-translational modifications. His lab investigates antibody uptake mechanisms and gut-brain axis interactions using animal models.
Recent publications highlight his work on viral protein structure (Camp Hill, Borealpox, Oropouche), microbiome analysis in ICUs, diet-immunotherapy interactions, and advancements in AI-driven vaccine design. He has also contributed to understanding SARS-CoV-2 pathogenesis, monoclonal antibody therapies, and microbiome-host health connections.
Patents include methods for disease treatment, Ehrlichia diagnostics, biosimulator technology, heat shock protein peptides, and vaccines against ehrlichiosis. Commercialized products like the IDO1 monoclonal antibody are now diagnostic probes in cancer research.
